|
US2002A
(en)
|
|
1841-03-12 |
|
Tor and planter for plowing |
|
US4736866B1
(en)
|
1984-06-22 |
1988-04-12 |
|
Transgenic non-human mammals
|
|
US5252334A
(en)
|
1989-09-08 |
1993-10-12 |
Cygnus Therapeutic Systems |
Solid matrix system for transdermal drug delivery
|
|
US5399363A
(en)
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
|
US5851832A
(en)
|
1991-07-08 |
1998-12-22 |
Neurospheres, Ltd. |
In vitro growth and proliferation of multipotent neural stem cells and their progeny
|
|
US5766948A
(en)
|
1993-01-06 |
1998-06-16 |
The Regents Of The University Of California |
Method for production of neuroblasts
|
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
|
US6001654A
(en)
|
1994-01-28 |
1999-12-14 |
California Institute Of Technology |
Methods for differentiating neural stem cells to neurons or smooth muscle cells using TGT-β super family growth factors
|
|
US5697899A
(en)
|
1995-02-07 |
1997-12-16 |
Gensia |
Feedback controlled drug delivery system
|
|
IE80468B1
(en)
|
1995-04-04 |
1998-07-29 |
Elan Corp Plc |
Controlled release biodegradable nanoparticles containing insulin
|
|
US6048964A
(en)
|
1995-12-12 |
2000-04-11 |
Stryker Corporation |
Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
|
|
US5656016A
(en)
|
1996-03-18 |
1997-08-12 |
Abbott Laboratories |
Sonophoretic drug delivery system
|
|
US5753506A
(en)
|
1996-05-23 |
1998-05-19 |
Cns Stem Cell Technology, Inc. |
Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals
|
|
US5797898A
(en)
|
1996-07-02 |
1998-08-25 |
Massachusetts Institute Of Technology |
Microchip drug delivery devices
|
|
US5783208A
(en)
|
1996-07-19 |
1998-07-21 |
Theratech, Inc. |
Transdermal drug delivery matrix for coadministering estradiol and another steroid
|
|
US5779708A
(en)
|
1996-08-15 |
1998-07-14 |
Cyberdent, Inc. |
Intraosseous drug delivery device and method
|
|
US5968829A
(en)
|
1997-09-05 |
1999-10-19 |
Cytotherapeutics, Inc. |
Human CNS neural stem cells
|
|
WO2001036623A2
(en)
*
|
1999-11-05 |
2001-05-25 |
Avigen, Inc. |
Ecdysone-inducible adeno-associated virus expression vectors
|
|
US6395546B1
(en)
|
2000-02-01 |
2002-05-28 |
Neurogeneration, Inc. |
Generation of dopaminergic neurons from human nervous system stem cells
|
|
WO2002064804A2
(en)
|
2001-02-13 |
2002-08-22 |
University Of Florida |
A bi-directional dual promoter complex with enhanced promoter activity for transgene expression in eukaryotes
|
|
JP4906231B2
(ja)
|
2001-09-14 |
2012-03-28 |
ステム セル セラピューティクス インコーポレイテッド |
プロラクチン誘導性の神経幹細胞数の増加ならびにその治療用途
|
|
WO2003072751A2
(en)
|
2002-02-25 |
2003-09-04 |
Vanderbilt University |
Expression system for human brain-specific voltage-gated sodium channel, type 1
|
|
WO2009012176A2
(en)
|
2007-07-14 |
2009-01-22 |
The University Of Iowa Research Foundation |
Methods and compositions for treating brain diseases
|
|
US20120308530A1
(en)
|
2011-06-03 |
2012-12-06 |
Beijing Allgens Medical Science & Technology Co., Ltd. |
Materials Composition and Methods to Control Neural Progenitor and Stem Cell Attachment, Proliferation and Guide Cell Differentiation
|
|
WO2013142337A1
(en)
|
2012-03-20 |
2013-09-26 |
The Trustees Of The University Of Pennsylvania |
Human papillomavirus 16 (hpv16) - related epilepsy
|
|
EP2888368A1
(en)
|
2012-08-27 |
2015-07-01 |
Friedrich Miescher Institute for Biomedical Research |
Retinal off circuit-specific promoter
|
|
DE102014207498A1
(de)
|
2014-04-17 |
2015-10-22 |
Universitätsklinikum Hamburg-Eppendorf |
Viraler Vektor für den zielgerichteten Gentransfer in Gehirn und Rückenmark
|
|
WO2016161124A1
(en)
*
|
2015-03-31 |
2016-10-06 |
New York University |
Compositions and method for reducing seizures
|
|
DK3081263T3
(da)
|
2015-04-17 |
2020-03-16 |
P&X Medical Nv |
Sammensætninger og redskaber til behandling af glaukom
|
|
WO2016186772A2
(en)
|
2015-05-16 |
2016-11-24 |
Genzyme Corporation |
Gene editing of deep intronic mutations
|
|
KR102423442B1
(ko)
|
2015-12-11 |
2022-07-20 |
캘리포니아 인스티튜트 오브 테크놀로지 |
아데노-관련 바이러스를 지시하기 위한 타겟팅 펩타이드
|
|
EA201992358A1
(ru)
*
|
2017-04-03 |
2020-03-24 |
Инкоудид Терапьютикс, Инк. |
Тканеселективная экспрессия трансгена
|
|
US11980671B2
(en)
|
2017-07-26 |
2024-05-14 |
Duke University |
Use of bacterial voltage gated ion channels for human therapies
|
|
AU2019253700B2
(en)
|
2018-04-09 |
2025-08-14 |
Allen Institute |
Rescuing voltage-gated sodium channel function in inhibitory neurons
|
|
JP7695192B2
(ja)
|
2018-10-08 |
2025-06-18 |
アレン インスティテュート |
介在ニューロンにおける遺伝子発現を選択的に調節するための人工発現構築物
|